Skip to main content

Table 3 Correlates of ACS ISR presentation compared to non-ACS presentation

From: In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Variables

Univariate analysis

Multivariate analysis

OR

Lower 95% CI

Upper 95% CI

P value

OR

Lower 95% CI

Upper 95% CI

P value

Patient-related

 Age

1.03

0.99

1.06

0.076

1.01

0.98

1.05

0.449

 Female gender

2.53

1.08

5.90

0.032

2.71

1.13

6.52

0.026

 BMI

1.04

0.93

1.17

0.476

 Diabetes

1.06

0.59

1.91

0.843

 Hypertension

1.17

0.65

2.10

0.601

 Current tobacco use

0.76

0.37

1.54

0.440

 Dyslipidemia

1.56

0.76

3.21

0.224

 Chronic kidney disease

4.20

1.19

14.80

0.026

3.85

1.05

14.20

0.043

 CCF

5.88

1.98

17.49

0.001

4.98

1.63

15.26

0.005

 Previous MI

1.33

0.74

2.39

0.338

 Previous CABG

1.12

0.36

3.49

0.841

 Statin therapy

0.73

0.31

1.72

0.475

    

Lesion-related

 LAD involvement

0.71

0.39

1.28

0.248

 Proximal ISR location

0.88

0.49

1.58

0.656

  1. ACS acute coronary syndrome, BMI body mass index, CABG coronary artery bypass grafting, CCF congestive cardiac failure, CI confidence interval, ISR in-stent restenosis, LAD left anterior descending, LVEF left ventricular ejection fraction, MI myocardial infarction, OR odds ratio